Drug class in one race
Pan-KRAS drugs for Non-Small Cell Lung Cancer
7 tracked Pan-KRAS drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the Pan-KRAS page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 1/25 Phase 11 preclinical / unstaged